(Q36794943)

16 August 2017

Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders (English)

1 reference

16 August 2017

1 reference

Thomas Walther

1

1 reference

PubMed ID

17442224

16 August 2017

Holger Stepan

series ordinal

2

1 reference

16 August 2017

1 April 2007

1 reference

Current Hypertension Reports

16 August 2017

1 reference

16 August 2017

9

1 reference

16 August 2017

2

1 reference

16 August 2017

128-132

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-007-0023-5

16 August 2017

0 references

cites work

How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-007-0023-5

Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature

21 January 2018

1 reference

12 December 2020

Angiotensin II and vascular inflammation.

1 reference

12 December 2020

Effect of endogenous vasoconstrictors on maternal intramyometrial and fetal stem villous arteries in pre-eclampsia

1 reference

12 December 2020

Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor

1 reference

12 December 2020

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

1 reference

12 December 2020

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

1 reference

12 December 2020

Preeclampsia: current understanding of the molecular basis of vascular dysfunction

1 reference

12 December 2020

Molecular mimicry and immune-mediated diseases

1 reference

12 December 2020

Interactions between angiotensin ll and atrial natriuretic peptide in renomedullary interstitial cells: the role of neutral endopeptidase

1 reference

12 December 2020

Anti-laminin auto antibodies in ANCA-associated vasculitis

1 reference

12 December 2020

Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension

1 reference

12 December 2020

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

1 reference

12 December 2020

Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia.

1 reference

12 December 2020

Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia

1 reference

12 December 2020

Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion

1 reference

12 December 2020

HELLP syndrome in the 18th week of gestation in association with elevated angiotensin AT(1)-receptor autoantibodies

1 reference

12 December 2020

Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence

1 reference

12 December 2020

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

1 reference

12 December 2020

The role of RAS in the pathogenesis of preeclampsia

1 reference

12 December 2020

Parvovirus B19 in human disease

1 reference

12 December 2020

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection

1 reference

12 December 2020

Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?

1 reference

12 December 2020

An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation

1 reference

12 December 2020

Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension

1 reference

12 December 2020

Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation

1 reference

12 December 2020

The prevalence of antibody to human parvovirus B19 in England and Wales

1 reference

12 December 2020

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity

1 reference

12 December 2020

High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction.

1 reference

12 December 2020

New aspects in the pathophysiology of preeclampsia

1 reference

12 December 2020

Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops

1 reference

12 December 2020

Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade

1 reference

12 December 2020

AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase

1 reference

12 December 2020

AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia

1 reference

12 December 2020

1 reference

12 December 2020

Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation

1 reference

12 December 2020

The spontaneous reversal of pre-eclampsia associated with parvovirus-induced hydrops and the placental theory of pre-eclampsia: a case report

1 reference

12 December 2020

Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells

1 reference

12 December 2020

The role of the AT1 angiotensin receptor in cardiac hypertrophy: angiotensin II receptor or stretch sensor?

1 reference

12 December 2020

A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity

1 reference

12 December 2020

Evidence of parvovirus B19 infection in patients of pre-eclampsia and eclampsia with dyserythropoietic anaemia

1 reference

12 December 2020

10.1007/S11906-007-0023-5

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17442224